Glucocorticoid resistance in childhood leukaemia: Mechanisms and modulation

British Journal of Haematology

Volumn 120, Issue 6, 2003, Pages 919-929

  Haarman, Eric G ^a   Kaspers, Gert Jan L ^a   Veerman, Anjo J P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Drug resistance; Glucocorticoids; Leukaemia; Paediatric

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 5 AZA 2' DEOXYCYTIDINE; 7 HYDROXYSTAUROSPORINE; BUTHIONINE SULFOXIMINE; CISPLATIN; CORTIVAZOL; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETACRYNIC ACID; ETOPOSIDE; FORSKOLIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; METHYLPREDNISOLONE; MINERALOCORTICOID; PACLITAXEL; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; CELL KILLING; CELL LINE; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYTOLYSIS; HUMAN; LIPOPHILICITY; LYMPHATIC SYSTEM TUMOR; MEDICAL RESEARCH; MODULATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROBABILITY; REGULATORY MECHANISM; REVIEW; SIDE EFFECT; THYMOCYTE; TREATMENT OUTCOME;

APOPTOSIS; CELL LINE; CHILD; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LYMPHOCYTES; RECEPTORS, GLUCOCORTICOID;

EID: 0037355622     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04189.x     Document Type: Review

References (122)

1. Adams, J. (2001) Proteasome inhibition in cancer: development of PS-341. Seminars in Oncology, 28, 613-619.
2. Adams, J.M. & Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-1326.
3. Antakly, T., O'Donnell, D. & Thompson, E.B. (1990) Immunocytochemical localization of the glucocorticoid receptor in steroid-sensitive and -resistant human leukemic cells. Cancer Research, 50, 1337-1345.
4. Ashraf, J. & Thompson, E.B. (1993) Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Molecular Endocrinology, 7, 631-642.
5. Ashraf, J., Kunapuli, S., Chilton, D. & Thompson, E.B.,(1991) Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells. Journal of Steroid Biochemistry and Molecular Biology, 38, 561-568.
6. Bamberger, C.M., Bamberger, A.M., de Castro, M. & Chrousos, G.P. (1995) Glucocorticold receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. Journal of Clinical Investigation, 95, 2435-2441.
7. Baughman, C., Harrigan, M.T., Campbell, N.F., Nurrish, S.J, & Bourgeois, S. (1991) Genes newly identified as regulated by glucocorticoids in murine thymocytes. Molecular Endocrinology, 5, 637-644.
8. Briehl, M.M., Flomerfelt, F.A., Wu, X.P. & Miesfeld, R.L. (1990) Transcriptional analyses of steroid-regulated gene networks. Molecular Endocrinology, 4, 287-294.
9. Briehl, M.M., Baker, A.F., Siemankowski, L.M. & Morreale, J. (1997) Modulation of antioxidant defenses during apoptosis. Oncology Research, 9, 281-285.
10. Broome, H.E., Yu, A.L., Diccianni, M., Camitta, B.M., Monia, B.P. & Dean, N.M. (2002) Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. Leukemia Research, 26, 311-316.
11. Chai, J., Du, C., Wu, J.W., Kyin, S., Wang, X. & Shi, Y. (2000) Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature, 406, 855-862.
12. Chandra, J., Niemer, I., Gilbreath, J., Kliche, K.O., Andreeff, M., Ereireich, E.J., Keating, M. & McConkey, D.J. (1998) Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood, 92, 4220-4229.
13. Conte, D., LIston, P., Wong, J.W., Wright, K.E. & Korneluk, R.G. (2001) Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation. Proceedings of the National Academy of Sciences of the United States of America, 98, 5049-5054.
14. Costlow, M.E. & Pui, C.H. (1987) Nuclear translocation of lymphoblast glucocorticoid receptors in childhood leukemia does not predict steroid responsiveness. Journal of Steroid Biochemistry, 26, 15-18.
15. Costlow, M.E., Pui, C.H. & Dahl, G.V. (1982) Glucocorticoid receptors in childhood acute lymphocytic leukemia. Cancer Research, 42, 4801-4806.
16. Coustan-Smith, E., Kitanaka, A., Pui, C.H., McNinch, L., Evans, W.E., Raimondi, S.C., Behm, F.G., Arico, M. & Campana, D. (1996) Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood, 87, 1140-1146.
17. De Bosscher, K., Schmitz, M.L., Van den Berghe, W., Plaisance, S., Fiers, W. & Haegeman, G. (1997) Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proceedings of the National Academy of Sciences of the United States of America. 94, 13504-13509.
18. De Lange, P., Segeren, C.M., Koper, J.W., Wiemer, E., Sonneveld, P., Brinkmann, A.O., White, A., Brogan, I.J., de J'ong, F.H. & Lamberts, S.W. (2001) Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Research. 61, 3937-3941.
19. Derenne, S., Mania, B., Dean, N.M., Taylor, J.K., Rapp, M.J., Harousseau, J.L., Bataille, R. & Amiot, M. (2002) Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood, 100, 194-199.
20. Deveraux, Q.L. & Reed, J.C. (1999) IAP family proteins: suppressors of apoptosis. Genes and Development, 13, 239-252.
21. Dowd, D.R. & Miesfeld, R.L. (1992) Evidence that glucocorticoid-and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events. Molecular and Cellular Biology, 12, 3600-3608.
22. Drouin, J., Charron, J., Cagner, J.P., Jeannotte, L., Nemer, M., Plante, R.K. & Wrange, O. (1987) Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. Journal of Cellular Biochemistry, 35, 293-304.
23. Feinman, R., Koury, J., Thames, M., Barlogie, B., Epstein, J. & Siegel, D.S. (1999) Role of NE-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood, 93, 3044-3052.
24. Furu, K., Kilvik, K., Gautvik, K.M. & Haug. E. (1987) The mechanism of [3H]dexamethasone uptake into prolactin producing rat pituitary cells (CH3 cells) in culture. Journal of Steroid Biochemistry, 28, 587-591.
25. Gala, J.L., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J.L., Philippe, M. & Martiat, P. (1994) High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis. Annals of Hematology, 69, 17-24.
26. Casson, J.C., Ryden, T. & Bourgeois, S. (1983) Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. Nature, 302, 621-623.
27. Caynon, P.S., Trigg, M.E., Heerema, N.A., Sensel, M.G., Sather, H.N., Hammond. G.D. & Bleyer, W.A. (2000) Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-95. Leukemia, 14, 2223-2233.
28. Gearing, K.L., Gustafsson, J.A. & Okret, S. (1993) Heterogeneity in the polyglutamine tract of the glucocorticoid receptor from different rat strains. Nucleic Acids Research, 21, 2014.
29. Gehring, U. & Segnitz, B. (1988) Modulation of DNA binding of glucocorticoid receptors. Molecular and Cellular Endocrinology, 56, 245-254.
30. Gehring, U. & Tomkins, G.M. (1974) A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor. Cell, 3, 301-306.
31. Gelfand, M.J. (1993) Meta-iodobenzylguanidine in children. Seminars in Nuclear Medicine. 23, 231-242.
32. Green, D.R. (2000) Apoptotic pathways: paper wraps stone blunts scissors. Cell, 102, 1-4.
33. Haarman, E.G., Kaspers, G.J.L., Pieters, R., Rottier, M.M.A. & Veerman, A.J.P. (2001) Modulation of glucocorticoid resistance in childhood leukemia. Hematology and Blood Transfusion, 40, 236-243.
34. Haarman, E.G., Kaspers, G.J.L., Pieters, R., Rottier, M.M.A. & Veerman, A.J.P. (2002) Temperature dependence of glucocorticoid receptor ligand binding. Leukemia (in press).
35. Hall, A.G., Autzen, P., Cattan, A.R., Malcolm, A.J., Cole, M., Kernahan, J. & Reid, M.M. (1994) Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia. Cancer Research, 54, 5251-5254.
36. Hamid, Q.A., Wenzel, S.E., Hauk, P.J., Tsicopoulos, A., Wallaert, B., Lafitte, J.J., Chrousos, G.P., Szefler, S.J. & Leung, D.Y. (1999) Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. American Journal of Respiratory and Critical Care Medicine, 159, 1600-1604.
37. Heck, S., Bender, K., Kullmann, M., Gottlicher, M., Herrlich, P. & Cato, A.C. (1997) I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO Journal, 16, 4698-4707.
38. Henze, G., Fengler, R., Hartmann, R., Kornhuber, B., Janka-Schaub, G., Niethammer, D. & Riehm, H. (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood, 78, 1166-1172.
39. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L. & Korsmeyer, S.J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251.
40. Homo, F., Dural, D., Harousseau, J.L., Marie, J.P. & Zittoun, R. (1980) Heterogeneity of the in vitro responses to glucocorticoids in acute leukemia. Cancer Research, 40, 2601-2608.
41. Hongo, T., Yajima, S., Sakurai, M., Horikoshi, Y. & Hanada, R. (1997) In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood, 89, 2959-2965.
42. Iacobelli, S., Ranelletti, F.O., Longo, P., Riccardi, R. & Mastrangelo, R. (1978) Discrepancies between in vivo and in vitro effects of glucorticoids in myelomonocytic leukemic cells with steroid receptors. Cancer Research, 38, 4257-4262.
43. Iacobelli, S., Marchetti, P., De Rossi, G., Mandelli, F. & Gentiloni, N. (1987) Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia, Oncology, 44, 13-16.
44. Ichii, S., Satoh, Y., Izawa, M. & Iwasaki, K. (1984) Stability of receptor complexes in the rat liver bound to glucocorticoids of different biopotencies. Endocrinology Japan, 31, 583-594.
45. Ito, C., Evans, W.E., McNinch, L., Coustan-Smith, E., Mahmoud, H., Pui, C.H. & Campana, D. (1996) Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 14, 2370-2376.
46. Jones, B., Freeman, A.I., Shuster, J.J., Jacquillat, C., Weil, M., Pochedly, C., Sinks, L., Chevalier, L., Maurer, H.M., Koch, K., Falkson, G., Patterson, R., Seligman, B., Sartorius, J., Kung, F., Haurani, F., Stuart, M., Burgert, E.O., Ruymann, F., Sawitsky, A., Forman, E., Pluess, H., Truman, J., Hakami, N., Glidewell, O., Glicksman, A.S. & Holland, J.F. (1991) Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Medical and Pediatric Oncology, 19, 269-275.
47. Kaspers, G.J.L., Pieters, R., Klumper, E., De Waal, F.C. & Veerman, A.J.P. (1994a) Glucocorticoid resistance in childhood leukemia. Leukemia and Lymphoma, 13, 187-201.
48. Kaspers, G.J.L., Kardos, G., Pieters, R., Van Zantwijk, C.H., Klumper, E., Hählen, K., De Waal, F.C., Van Wering, E.R. & Veerman, A.J.P. (1994b) Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. Leukemia, 8, 1224-1229.
49. Kaspers, G.J.L., Veerman, A.J.P., Popp-Snijders, C., Lomecky, M., Van Zantwijk, C.H., Swinkels, L.M., Van Wering, E.R. & Pieters, R. (1996) Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Medical and Pediatric Oncology, 27. 114-121.
50. Kaspers, G.J.L., Veerman, A.J.P., Pieters, R., Van Zantwijk, C.H., Smets, L.A., Van Wering, E.R. & Van der Does-van den Berg. A. (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood, 90, 2723-2729.
51. Kato, G.J., Ouddus, F.F., Shuster, J.J., Boyett, J., Pullen, J.D., Borowitz, M.J., Whitehead, V.M., Crist, W.M. & Leventhal, B.G. (1993 ) High glucocorticoid receptor content o f leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood. 82, 2304-2309.
52. Kearns, P.R., Pieters, R., Rottier, M.M., Pearson, A.D. & Hall, A.G. (2001) Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Blood, 97, 393-398.
53. Keith, F.J., Bradbury, D.A., Zhu, Y.M. & Russell, N.H. (1995) Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. Leukemia, 9, 131-138.
54. Kitada, S., Takayama, S., De Riel, K., Tanaka, S. & Reed, J.C. (1994) Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Research and Development, 4, 71-79.
55. Klumper, E., Pieters, R., Veerman, A.J.P., Huismans, D.R., Loonen, A.H., Hählen, K., Kaspers, G.J.L., Van Wering, E.R., Hartmann, R. & Henze, G. (1995) In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood, 86, 3861-3868.
56. Knospe, W.H. & Conrad, M.E. (1966) The danger of corticosteroids in acute granulocytic leukemia. Medical Clinics of North America. 50, 1653-1668.
57. Kofler, R. (2000) The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochemistry and Cell Biology, 114, 1-7.
58. Kornblau, S.M., Konopleva, M. & Andreeff, M. (1999) Apoptosis regulating proteins as targets of therapy for haematological malignancies. Expert Opinion on Investigational Drugs, 8, 2027-2057.
59. LaCasse, E.C., Baird, S., Korneluk, R.G. & MacKenzie, A.E. (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene, 17, 3247-3259.
60. Langeveld, C.H., van Waas, M.P., Stoof, J.C., Sutanto, W., De Kloet, E.R., Wolbers, J.G. & Heimans, J.J. (1992) Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone. Journal of Neuroscientific Research, 31, 524-531.
61. Lebedeva, I., Raffo, A., Rando, R., Ojwang, J., Cossum, P. & Stein, C.A. (2001) Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides. Journal of Urology, 166, 461-469.
62. Longui, C.A., Vottero, A., Adamson, P.C., Cole, D.E., Kino, T., Monte, O. & Chrousos, G.P. (2000) Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia. Hormone and Metabolic Research, 32, 401-406.
63. Mastrangelo, R., Malandrino, R., Riccardi, R., Longo, P., Ranelletti, F.O. & Iacobelli, S. (1980) Clinical implications of glucocorticoid receptor studies in childhood acute lymphoblastic leukemia. Blood, 56, 1036-1040.
64. Maung, Z.T., Hogarth, L., Reid, M.M., Proctor, S.J., Hamilton, P.J. & Hall, A.G. (1994a) Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukemia. Leukemia, 8, 1487-1491.
65. Maung, Z.T., MacLean, F.R., Reid, M.M., Pearson, A.D., Proctor, S.J., Hamilton, P.J. & Hall, A.G. (1994b) The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. British Journal of Haematology, 88, 105-109.
66. Medh, R.D., Saeed, M.F., Johnson, B.H. & Thompson, E.B. (1998) Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Cancer Research, 58, 3684-3693.
67. Messmer, U.K., Winkel, G., Briner, V.A. & Pfeilschifter, J. (2000) Suppression of apoptosis by glucocorticoids in glomerular endothelial cells; effects on proapoptotic pathways. British Journal of Pharmacology, 129, 1673-1683.
68. Messmer, U.K., Pereda-Fernandez, C., Manderscheid, M. & Pfeilschifter, J. (2001) Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells. British Journal of Pharmacology, 133, 467-476.
69. Miesfeld, R., Godowski, P.J., Maler, B.A. & Yamamoto, K.R. (1987) Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science, 236, 423-427.
70. Miyashita, T. & Reed, J.C. (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81, 151-157.
71. Miyata, Y. & Yahara, I. (1991) Cytoplasmic 8 S glucocorticoid receptor binds to actin filaments through the 90-kDa heat shock protein moiety. Journal of Biological Chemistry, 266, 8779-8783.
72. Moalli, P.A. & Rosen, S.T. (1994) Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies. Leukemia and Lymphoma, 15, 363-374.
73. Moulding, D.A., Giles, R.V., Spiller, D.G., White, M.R., Tidd, D.M. & Edwards, S.W. (2000) Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood, 96, 1756-1763.
74. O'Dwyer, P.J., Hamilton, T.C., Yao, K.S., Tew, K.D. & Ozols, R.F. (1995) Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs. Hematology/Oncology Clinics of North America, 9, 383-396.
75. Palmer, L.A. & Harmon, J.M. (1991) Biochemical evidence that glucocorticoid-sensitive cell lines derived from the human leukemic cell line CCRF-CEM express a normal and a mutant glucocorticoid receptor gene. Cancer Research, 51, 5224-5231.
76. Pfahl, M., Kelleher, Jr. R.J. & Bourgeois, S. (1978) General features of steroid resistance on lymphoid cell lines. Molecular and Cellular Endocrinology, 10, 193-207.
77. Ponec, M., Kempenaar, J., Shroot, B. & Caron, J.C. (1986) Glucocorticoids: binding affinity and lipophilicity. Journal of Pharmaceutical Sciences, 75, 973-975.
78. Powers, J.H., Hillmann, A.G., Tang, D.C. & Harmon, J.M. (1993) Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells. Cancer Research, 53, 4059-4065.
79. Prima, V., Depoix, C., Masselot, B., Formstecher, P. & Lefebvre, P. (2000) Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds. Journal of Steroid Biochemistry and Molecular Biology, 72, 1-12.
80. Prokop, A., Wieder, T., Sturm, I., Essmann, F., Seeger, K., Wuchter, C., Ludwig, W.D., Henze, G., Dorken, B. & Daniel, P.T. (2000) Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia, 14, 1606-1613.
81. Pui, C.H. & Costlow, M.E. (1986) Sequential studies of lymphoblast glucocorticoid receptor levels at diagnosis and relapse in childhood leukemia: an update. Leukemia Research, 10, 227-229.
82. Pui, C.H., Costlow, M.E., Kalwinsky, D.K. & Dahl, G.V. (1983) Glucocorticoid receptors in childhood acute non-lymphocytic leukemia. Leukemia Research, 7, 11-16.
83. Pui, C.H., Ochs, J., Kalwinsky, D.K. & Costlow, M.E. (1984) Impact of treatment efficacy on the prognostic value of glucocorticoid receptor levels in childhood acute lymphoblastic leukemia. Leukemia Research, 8, 345-350.
84. Quddus, F.F., Leventhal, B.G., Boyett, J.M., Pullen, D.J., Crist, W.M. & Borowitz, M.J. (1985) Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group Study. Cancer Research, 45, 6482-6486.
85. Ray, A. & Prefontaine, K.E. (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America, 91, 752-756.
86. Reed, J.C., Kitada, S., Takayama, S. & Miyashita, T. (1994) Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Annals of Oncology., 5, 61-65.
87. Riehm, H., Reiter, A., Schrappe, M., Berthold, F., Dopfer, R., Gerein, V., Ludwig, R., Ritter, J., Stollmann, B. & Henze, G. (1987) Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klinische Padiatrie, 199, 151-160.
88. Rivers, C., Levy, A., Hancock, J., Lightman, S. & Norman, M. (1999) Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. Journal of Clinical Endocrinology and Metabolism, 84, 4283-4286.
89. Salomons, G.S., Brady, H.J., Verwijs-Janssen, M., van den Berg, J.D., Hart, A.A., Van den Berg, H., Behrendt, H., Hählen, K. & Smets, L.A. (1997) The Bax alpha: Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. International Journal of Cancer, 71, 959-965.
90. Salomons, G.S., Smets, L.A., Verwijs-Janssen, M., Hart, A.A., Haarman, E.G., Kaspers, G.J.L., Van Wering, E.R., Van der Does-van den Berg, A. & Kamps, W.A. (1999) Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia, 13, 1574-1580.
91. Sasaki, H., Sheng, Y., Kotsuji, F. & Tsang, B.K. (2000) Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Research, 60, 5659-5666.
92. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K. & Baldwin, Jr. A.S. (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science, 270, 283-286.
93. Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W.D., Henze, G., Gadner, H., Odenwald, E. & Riehm, H. (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia, 14, 2205-2222.
94. Selye, H. (1936) Thymus and adrenals in the response of the organism to injuries and antioxidants. British Journal of Experimental Pathology, 17, 234-238.
95. Shanbrom, E. & Miller, S. (1962) Critical evaluation of massive steroid therapy of acute leukemia. New England Journal of Medicine, 266, 1354-1363.
96. Smets, L., Metwally, E.A., Knol, E. & Martens, M. (1988) Potentiation of glucocorticoid-induced lysis in refractory and resistant leukemia cells by inhibitors of ADP-ribosylation. Leukemia Research, 12, 737-743.
97. Smets, L.A., Loesberg, C., Janssen, M. & Van Rooij, H. (1990) Intracellular inhibition of mono (ADP-ribosylation) by meta-iodobenzylguanidine: specificity, intracellular concentration and effects on glucocorticoid-mediated cell lysis. Biochimica et Biophysica Acta, 1054, 49-55.
98. Smets, L.A., Van den Berg, J.D., Acton, D., Top, B., Van Rooij, H. & Verwijs-Janssen, M. (1994) BCL-2 expression and mitochonclrial activity in leukemic cells with different sensitivity to glucocorticold-induced apoptosis. Blood, 84, 1613-1619.
99. Srivastava, D. & Thompson, E.B. (1990) Two glucocorticoid binding sites on the human glucocorticoid receptor. Endocrinology, 127, 1770-1778.
100. Stevens, R.F., Hann, I.M., Wheatley, K. & Gray, R.G. (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. British Journal of Haematology, 101, 130-140.
101. Strahle, U., Schmidt, A., Kelsey, G., Stewart, A.F., Cole, T.J., Schmid, W. & Schutz, G. (1992) At least three promoters direct expression of the mouse glucocorticoid receptor gene. Proceedings of the National Academy of Sciences of the United States of America, 89, 6731-6735.
102. Strasser-Wozak, E.M., Hattmannstorfer, R., Hala, M., Hartmann, B.L., Fiegl, M., Geley, S. & Kofler, R. (1995) Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Research, 55, 348-353.
103. Tao, Y., Williams-Skipp, C. & Scheinman, R.I. (2001) Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. Journal of Biological Chemistry, 276, 2329-2332.
104. Thompson, E.B. (1998) The many roles of c-Myc in apoptosis. Annual Review of Physiology, 60, 575-600.
105. Thompson, E.B. & Harmon, J.M. (1986) Glucocorticoid receptors and glucocorticoid resistance in human leukemia in vivo and in vitro. Advances in Experimental Medicine and Biology, 196, 111-127.
106. Thompson, E.B., Srivastava, D. & Johnson, B.H. (1989) Interactions of the phenylpyrazolo steroid cortivazol with glucocorticoid receptors in steroid-sensitive and -resistant human leukemic cells. Cancer Research, 49, 2253s-2258s.
107. Thulasi, R., Harbour, D.V. & Thompson, E.B. (1993) Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. Journal of Biological Chemistry, 268, 18306-18312.
108. Tonko, M., Ausserlechner, M.J., Bernhard, D., Helmberg, A. & Kofler, R. (2001) Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB Journal, 15, 693-699.
109. Van den Berg, J.D., Smets, L.A., Van den Elshout, M.M., Van Geel, I.P. & Janssen, M. (1993) Temperature dependence of glucocorticoid binding in sensitive and refractory murine leukaemia cells. Leukemia Research, 17, 263-269.
110. Van Hal, P.T., Mulder, E., Hoogsteden, H.C. & Hilvering, C. (1989) 1949-89: glucocorticoids, their receptors and variable clinical response. Nederlands Tijdschrift Voor Geneeskunde, 133, 1305-1310.
111. Vayssiere, B.M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H. & Resche-Rigon, M. (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Molecular Endocrinology, 11, 1245-1255.
112. Veerman, A.J.P., Hählen, K., Kamps, W.A., Van Leeuwen, E.F., De Vaan, G.A., Solbu, G., Suciu, S., Van Wering, E.R. & Van der Does-van der Berg. A. (1996) High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. Journal of Clinical Oncology, 14, 911-918.
113. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V. & Baldwin. Jr. A.S. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 281, 1680-1683.
114. Wang, J.L., Liu, D., Zhang, Z.J., Shan, S., Han, X., Srinivasula, S.M., Croce, C.M., Alnemri, E.S. & Huang, Z. (2000) Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 97, 7124-7129.
115. Wright, A.P., Zilliacus, J., McEwan, I.J., Dahlman-Wright, K., Almlof, T., Carlstedt-Duke, J. & Gustafsson, J.A. (1993) Structure and function of the glucocorticoid receptor. Journal of Steroid Biochemistry and Molecular Biology, 47, 11-19.
116. Xie, H., Seward, R.J. & Huber, B.T. (1997) Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IkappaBalpha. Molecular Immunology, 34, 987-994.
117. Yamamoto, K.R. (1985) Steroid receptor regulated transcription of specific genes and gene networks. Annual Review of Genetics, 19, 209-252.
118. Yamamoto, K.R. & Alberts, B.M. (1976) Steroid receptors: elements for modulation of eukaryotic transcription. Annual Review of Biochemistry, 45, 721-746.
119. Yang, Y. & Ashwell, J.D. (1999) Thymocyte apoptosis. Journal of Clinical Immunology, 19, 337-349.
120. Yang, Y., Fang, S., Jensen, J.P., Weissman, A.M. & Ashwell, J.D. (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science, 288, 874-877.
121. Zeelen, F.J. (1990) Determination of the affinity of a steroid for its receptor is not sufficient to measure its intrinsic hormonal activity. Steroids, 55, 325-326.
122. Zwaan, C.M., Kaspers, G.J.L., Pieters, R., Ramalers-van Woerden, N.L., Den Boer, M.L., Wünsche, R., Rottier, M.M.A., Hählen, K., Van Wering, E.R., Janka-Schaub, G.E., Creutzig, U. & Veerman. A.J.P. (2000) Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood, 96, 2879-2886.